Katlama C - Search Results

1

High uptake of vaccination against mpox in men who have sex with men (MSM) on HIV pre-exposure prophylaxis (PrEP) in Paris, France.

Palich R, Jedrzejewski T, Schneider L, Qatib N, Orriere T, Gosset D, Grunemwald T, Pataut D, Ohayon M, Katlama C. Palich R, et al. Among authors: katlama c. Sex Transm Infect. 2023 Dec;99(8):552-553. doi: 10.1136/sextrans-2023-055885. Epub 2023 Jul 28. Sex Transm Infect. 2023. PMID: 37507222 Free article. No abstract available.

2

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.

Ghosn J, Lamotte C, Ait-Mohand H, Wirden M, Agher R, Schneider L, Bricaire F, Duvivier C, Calvez V, Peytavin G, Katlama C. Ghosn J, et al. Among authors: katlama c. AIDS. 2003 Jan 24;17(2):209-14. doi: 10.1097/00002030-200301240-00011. AIDS. 2003. PMID: 12545081 Clinical Trial.

3

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.

Wirden M, Delaugerre C, Marcelin AG, Ktorza N, Ait Mohand H, Dominguez S, Schneider L, Ghosn J, Pauchard M, Costagliola D, Katlama C, Calvez V. Wirden M, et al. Among authors: katlama c. Antimicrob Agents Chemother. 2004 Feb;48(2):644-7. doi: 10.1128/AAC.48.2.644-647.2004. Antimicrob Agents Chemother. 2004. PMID: 14742228 Free PMC article. Clinical Trial.

4

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

Duvivier C, Myrto A, Marcelin AG, Ghosn J, Ait-Mohand H, Schneider L, Agher R, Bricaire F, Costagliola D, Calvez V, Peytavin G, Katlama C. Duvivier C, et al. Among authors: katlama c. Antivir Ther. 2003 Dec;8(6):603-9. Antivir Ther. 2003. PMID: 14760894

5

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.

Ghosn J, Wirden M, Ktorza N, Peytavin G, Aït-Mohand H, Schneider L, Dominguez S, Bricaire F, Calvez V, Costagliola D, Katlama C. Ghosn J, et al. Among authors: katlama c. AIDS. 2005 Oct 14;19(15):1643-7. doi: 10.1097/01.aids.0000181322.17679.b2. AIDS. 2005. PMID: 16184034 Clinical Trial.

6

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.

Wirden M, Lambert-Niclot S, Marcelin AG, Schneider L, Ait-Mohand H, Brunet C, Angleraud F, Amard S, Katlama C, Calvez V. Wirden M, et al. Among authors: katlama c. AIDS. 2009 Jan 2;23(1):95-9. doi: 10.1097/QAD.0b013e328319bc91. AIDS. 2009. PMID: 19050391

7

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.

Wirden M, Simon A, Schneider L, Tubiana R, Malet I, Ait-Mohand H, Peytavin G, Katlama C, Calvez V, Marcelin AG. Wirden M, et al. Among authors: katlama c. J Antimicrob Chemother. 2009 Nov;64(5):1087-90. doi: 10.1093/jac/dkp310. Epub 2009 Aug 27. J Antimicrob Chemother. 2009. PMID: 19717396

8

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients.

Canestri A, Krivine A, Assoumou L, Le Corre M, Rozenberg F, Marcelin AG, Schneider L, Samri A, Carcelain G, Autran B, Katlama C, Guihot A. Canestri A, et al. Among authors: katlama c. AIDS. 2010 Nov 27;24(18):2887-9. doi: 10.1097/QAD.0b013e3283402bc1. AIDS. 2010. PMID: 20962616

9

Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.

Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C. Calin R, et al. Among authors: katlama c. Antivir Ther. 2012;17(8):1601-4. doi: 10.3851/IMP2344. Epub 2012 Sep 3. Antivir Ther. 2012. PMID: 22941896

10

Pitfalls of HIV genotypic tropism testing after treatment interruption.

Wirden M, Soulié C, Fourati S, Valantin MA, Simon A, Ktorza N, Tubiana R, Bonmarchand M, Schneider L, Calvez V, Katlama C, Marcelin AG. Wirden M, et al. Among authors: katlama c. J Antimicrob Chemother. 2013 Jan;68(1):188-9. doi: 10.1093/jac/dks362. Epub 2012 Sep 6. J Antimicrob Chemother. 2013. PMID: 22954492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

930 results

Search Page